Maryland Psychiatric Research Center and Oxford University Press
1745-1701
Quarterly
6.7
1969
4107063100
United Kingdom
English
YES
Google Scholar
StudentResearch@som.umaryland.edu
Schizophrenia Bulletin seeks to publish recent developments and empirically based hypotheses regarding the etiology, pathophysiology and treatment of schizophrenia and related disorders. We view the field as broad and deep and will publish new knowledge ranging from molecular to social and cultural factors. We will give new emphasis to translational reports which simultaneously highlight basic neurobiological mechanisms and clinical manifestations. Some of the Bulletin content is invited as special features or manuscripts organized as a theme by special guest editors. Most pages of the Bulletin are devoted to unsolicited manuscripts of high quality that report original data or where we can provide a special venue for a major study or workshop report. Supplement issues are sometimes arranged for reports from a recent conference or proposed to highlight a specific area. The editorial policy of the Schizophrenia Bulletin generally follows the Uniform Requirements guidelines articulated by the International Committee of Medical Journal Editors. The journal publishes six issue a year and has an international readership. The Bulletin is an ideal venue for special reports such as treatment guidelines or changes in nosology. The Bulletin will publish At Issue articles expressing opposing views on controversial scientific issues, succinct discourses on clinical and basic neuroscience concepts, and brief essays on the role of specific environmental and genetic factors in schizophrenia. Schizophrenia Bulletin will continue the tradition of the front cover display of art from artists with mental illness and first person accounts informing on the lived experience of psychosis.
Minor neurological signs are subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts present in excess in the early stages of psychosis. Still, it re...
Background Insulin Resistance (IR) predisposes to cardiometabolic disorders, which are common in schizophrenia and are associated with excess morbidity and mortality. The mechanisms of asso...
Background A number of psychological symptoms have been found to predict psychosis. Many studies have found no specificity to separate symptoms predicting non-psychotic psychiatric disorder...
Background Cardiometabolic risk prediction algorithms are used in clinical practice. Young people with psychosis are a high-risk group for developing cardiometabolic disorders, but it is un...
Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may ha...
Background Increasing evidence supports the benefits of regular aerobic exercise for cognition and functioning in schizophrenia. The extent to which these gains are dependent on the amount ...
Development of schizophrenia relates to both genetic and environmental factors. Functional deficits in many cognitive domains, including the ability to communicate in social interactions and...
Background Schizophrenia affects over 20 million people worldwide through a wide range of symptoms. As an incurable disorder, the disease management is normally based in antipsychotics, whi...
Background Importance: Associations between childhood infection, IQ and adult non-affective psychosis (NAP) are well established. However, examination of sensitive periods for exposure, eff...
Background Subclinical metabolic dysfunction and inflammation have been associated with early psychosis and depression, suggesting the possibility of an intrinsic association. This may be d...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!